Renaissance Technologies’s Clearside Biomedical CLSD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$397K Sell
496,589
-57,923
-10% -$46.3K ﹤0.01% 2949
2025
Q1
$509K Sell
554,512
-167,277
-23% -$154K ﹤0.01% 2738
2024
Q4
$686K Sell
721,789
-23,100
-3% -$21.9K ﹤0.01% 2692
2024
Q3
$946K Buy
744,889
+162,200
+28% +$206K ﹤0.01% 2479
2024
Q2
$757K Buy
582,689
+35,900
+7% +$46.7K ﹤0.01% 2480
2024
Q1
$837K Buy
546,789
+162,100
+42% +$248K ﹤0.01% 2587
2023
Q4
$450K Buy
384,689
+111,400
+41% +$130K ﹤0.01% 2829
2023
Q3
$238K Sell
273,289
-63,400
-19% -$55.2K ﹤0.01% 3029
2023
Q2
$377K Sell
336,689
-122,700
-27% -$137K ﹤0.01% 3020
2023
Q1
$478K Sell
459,389
-128,003
-22% -$133K ﹤0.01% 2913
2022
Q4
$658K Sell
587,392
-71,097
-11% -$79.6K ﹤0.01% 2778
2022
Q3
$744K Sell
658,489
-149,300
-18% -$169K ﹤0.01% 2676
2022
Q2
$1.19M Sell
807,789
-57,162
-7% -$84K ﹤0.01% 2595
2022
Q1
$1.98M Buy
864,951
+435,734
+102% +$998K ﹤0.01% 2240
2021
Q4
$1.18M Buy
429,217
+327,728
+323% +$901K ﹤0.01% 2524
2021
Q3
$609K Buy
101,489
+30,900
+44% +$185K ﹤0.01% 2799
2021
Q2
$344K Sell
70,589
-493,910
-87% -$2.41M ﹤0.01% 3099
2021
Q1
$1.39M Buy
564,499
+105,110
+23% +$260K ﹤0.01% 2440
2020
Q4
$1.26M Sell
459,389
-69,600
-13% -$191K ﹤0.01% 2386
2020
Q3
$815K Sell
528,989
-282,449
-35% -$435K ﹤0.01% 2613
2020
Q2
$1.53M Buy
811,438
+418,550
+107% +$787K ﹤0.01% 2328
2020
Q1
$668K Buy
392,888
+304,187
+343% +$517K ﹤0.01% 2619
2019
Q4
$257K Buy
+88,701
New +$257K ﹤0.01% 3106
2019
Q2
Sell
-26,717
Closed -$37K 3563
2019
Q1
$37K Sell
26,717
-479,707
-95% -$664K ﹤0.01% 3372
2018
Q4
$542K Buy
506,424
+471,324
+1,343% +$504K ﹤0.01% 2835
2018
Q3
$216K Buy
+35,100
New +$216K ﹤0.01% 3128
2017
Q3
Sell
-80,200
Closed -$731K 3216
2017
Q2
$731K Buy
80,200
+4,100
+5% +$37.4K ﹤0.01% 2664
2017
Q1
$604K Buy
+76,100
New +$604K ﹤0.01% 2716